Form 8-K TENET HEALTHCARE CORP For: Jul 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Tenet Healthcare (THC) PT Raised to $170 at Mizuho
July 26, 2024 1:55 PM EDTMizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $170.00 (from $145.00) while maintaining a Outperform rating.
The analyst comments "We are raising our estimates, and raising our price target on THC to $170 from $145. Highlights of the quarter include... More
Tenet Healthcare (THC) PT Raised to $160 at Deutsche Bank
July 25, 2024 5:06 AM EDTDeutsche Bank analyst Pito Chickering raised the price target on Tenet Healthcare (NYSE: THC) to $160.00 (from $155.00) while maintaining a Buy rating.
The analyst comments "Updated 2024 guidance of $3.9b EBITDA for 2024 and $3.975b at the high end is within spitting distance of consensus... More
Tenet Healthcare (THC) PT Raised to $171 at Citi
July 24, 2024 4:47 PM EDTCiti analyst Jason Cassorla raised the price target on Tenet Healthcare (NYSE: THC) to $171.00 (from $139.00) while maintaining a Buy rating.
The analyst comments "2Q24 EBITDA of $945M ($915 ex retro TX) was ahead of expectations, driven by strength in USPI rev/case, hospital volume... More
